Oxygenta Pharmaceutical (BOM:524636) GF Value Rank: 8 (As of Sep. 21, 2026) — 167% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524636 Oxygenta Pharmaceutical Ltd BOM:524636
55 GF Score
Price ₹53.20
GF Value ₹85.60
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Oxygenta Pharmaceutical GF Value Rank?

Oxygenta Pharmaceutical BOM:524636 +0.38% 55 GF Value Rank is 8 as of Sep. 21, 2026, which is 167% above its 10-year median of 3.00. GuruFocus rates BOM:524636 with a GF Score™ of 55/100 and a GF Value™ of ₹85.60 (Possible Value Trap). The stock has 5 warning signs investors should review.

Oxygenta Pharmaceutical has the GF Value Rank of 8.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Oxygenta Pharmaceutical GF Value Rank Related Terms


BOM:524636 vs ZTS: GF Value Rank Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Oxygenta Pharmaceutical's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxygenta Pharmaceutical GF Value Rank vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Oxygenta Pharmaceutical's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Oxygenta Pharmaceutical's GF Value Rank falls into.


BOM:524636
55GF Score
Oxygenta Pharmaceutical Ltd BOM:524636
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 8 mean?
Oxygenta Pharmaceutical (BOM:524636) has a GF Value Rank of 8 as of Sep. 21, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Oxygenta Pharmaceutical and its competitors. This is 167% above median its historical median of 3.00. Over the past decade, Oxygenta Pharmaceutical's GF Value Rank has ranged from 1.00 to 10.00.
Is Oxygenta Pharmaceutical's GF Value Rank too high?
Oxygenta Pharmaceutical's current GF Value Rank of 8 is 167% above median its 10-year median of 3.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, Oxygenta Pharmaceutical has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Oxygenta Pharmaceutical's GF Value Rank compare to ZTS?
Oxygenta Pharmaceutical's GF Value Rank of 8 can be compared against companies in the Drug Manufacturers industry. Historically, Oxygenta Pharmaceutical's own GF Value Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Drug Manufacturers company?
A good GF Value Rank depends on the Drug Manufacturers industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Oxygenta Pharmaceutical and its competitors. Oxygenta Pharmaceutical's current GF Value Rank is 8, which is 167% above median its own 10-year median of 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxygenta Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, Oxygenta Pharmaceutical (BOM:524636) is currently considered Possible Value Trap. The stock's GF Value™ is ₹85.60, compared to a current price of ₹53.20 — trading 37.9% below its estimated fair value. The current GF Value Rank is 8, which is 167% above median its 10-year median of 3.00. Oxygenta Pharmaceutical's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For Oxygenta Pharmaceutical (BOM:524636), the current GF Value Rank is 8 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oxygenta Pharmaceutical (BOM:524636) Overvalued in 2026?

Based on GuruFocus' analysis, Oxygenta Pharmaceutical stock appears to be undervalued. The current stock price of ₹53.20 is trading 37.9% below its estimated GF Value™ of ₹85.60. GuruFocus considers Oxygenta Pharmaceutical to be Possible Value Trap.

Key valuation signals for BOM:524636:

  • GF Value Rank: 8 (167% above median its 10-year median of 3.00)
  • GF Value™: ₹85.60 vs. price of ₹53.20 (37.9% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the BOM:524636 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Oxygenta Pharmaceutical Business Description

Address Plot No. B1 & B2, IDA Gandhi Nagar, Kukatpally, Hyderabad, TG, IND, 500037
Oxygenta Pharmaceutical Ltd is a pharmaceutical company. It is engaged in the business activity of is engaged in manufacturing and selling of Pharmaceutical, medical, and veterinary preparations. The Company has one reportable segment, which is Pharmaceutical. The group carries out its business operations within India.
55GF Score

Get the complete analysis for BOM:524636

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹53.20
Price
₹85.60
GF Value